Literature DB >> 6579058

Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline.

J Slots, B G Rosling.   

Abstract

Since recent studies have implicated Actinobacillus actinomycetemcomitans in the etiology of localized juvenile periodontitis, this investigation determined the effectiveness of subgingival debridement, topical Betadine Solution, and systemic tetracycline in suppressing subgingival A. actinomycetemcomitans and other microorganisms. A total of 20 deep periodontal pockets and 10 normal periodontal sites of 6 localized juvenile periodontitis patients was included in the study. Each patient was treated in 3 stages over a period of 22 weeks, and the result of treatment was monitored for an additional 38 weeks. The first stage of treatment included plaque control, as well as thorough scaling and root planing, composed of at least 6 h of debridement. No concomitant periodontal surgery was performed. In the second stage, Betadine saturated cotton gauze was inserted into the periodontal pockets for 10 min. Stage 3 involved systemic tetracycline therapy (1 g/day) for 14 days. The subgingival microflora was determined at frequent intervals by selective culturing of A. actinomycetemcomitans and Capnocytophaga and by direct microscopic examination. The clinical effect was assessed by measuring changes in probing periodontal attachment level, probing periodontal pocket depth, radiographic alveolar bone mass, and other relevant clinical parameters. Scaling and root planing reduced the total subgingival bacterial counts and the proportions of certain Gram-negative bacteria, but no periodontal pocket became free of A. actinomycetemcomitans. Betadine application had little or no effect on the subgingival microflora. In contrast, tetracycline administered via the systemic route suppressed A. actinomycetemcomitans, Capnocytophaga, and spirochetes to low or undetectable levels in all test periodontal pockets. A. actinomycetemcomitans reappeared in 9 of the deep periodontal pockets after the administration of tetracycline. Most of these 9 pockets became free of detectable A. actinomycetemcomitans during the second week of tetracycline administration, whereas pockets which yielded no A. actinomycetemcomitans after tetracycline therapy became free of the organisms during the first week of tetracycline treatment. This data suggests that systemic tetracycline therapy of localized juvenile periodontitis should, as a practical rule, be continued for 3 weeks. Periodontal destruction continued in 4 deep pockets which all showed high posttetracycline A. actinomycetemcomitans counts. All 6 pockets which demonstrated a marked gain in periodontal attachment yielded no cultivable A. actinomycetemcomitans. No association was found between periodontal disease status and subgingival Capnocytophaga, spirochetes or motile rods. The present study indicates that A. actinomycetemcomitans is an important etiologic agent in localized juvenile periodontitis.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6579058     DOI: 10.1111/j.1600-051x.1983.tb02179.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  26 in total

1.  In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations.

Authors:  M J Pavicić; A J van Winkelhoff; J de Graaff
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

2.  Synergistic effects between amoxicillin, metronidazole, and the hydroxymetabolite of metronidazole against Actinobacillus actinomycetemcomitans.

Authors:  M J Pavicić; A J van Winkelhoff; J de Graaff
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 3.  [The GTR technic within the framework of combined periodontal-orthodontic treatments. A case report].

Authors:  M Stelzel; L Flores-de-Jacoby
Journal:  Fortschr Kieferorthop       Date:  1995-11

4.  The role of Actinobacillus actinomycetemcomitans in periodontal disease.

Authors:  J de Graaff; A J van Winkelhoff; R J Goené
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

5.  Non-Surgical Therapy Reduces Presence of JP2 Clone in Localized Aggressive Periodontitis.

Authors:  Danielle K Burgess; Hong Huang; Peter Harrison; Theodora Kompotiati; Ikramuddin Aukhil; Luciana M Shaddox
Journal:  J Periodontol       Date:  2017-08-18       Impact factor: 6.993

6.  Reevaluation of the chromosome 4q candidate region for early onset periodontitis.

Authors:  T C Hart; M L Marazita; K M McCanna; H A Schenkein; S R Diehl
Journal:  Hum Genet       Date:  1993-06       Impact factor: 4.132

7.  Azithromycin enhances phagocytic killing of Aggregatibacter actinomycetemcomitans Y4 by human neutrophils.

Authors:  Pin-Chuang Lai; Mark R Schibler; John D Walters
Journal:  J Periodontol       Date:  2015-01       Impact factor: 6.993

8.  Effect of biologic mediators on ciprofloxacin accumulation by gingival fibroblasts.

Authors:  Swati Y Rawal; John D Walters
Journal:  J Periodontol       Date:  2005-12       Impact factor: 6.993

9.  The effect of clindamycin gel insert in periodontal pockets, as observed on smears and cultures.

Authors:  E Sauvêtre; Y Glupczynsky; M Labbé; E Yourassowsky; M Pourtois
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

10.  In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans.

Authors:  R Pajukanta; S Asikainen; M Saarela; S Alaluusua; H Jousimies-Somer
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.